NDC 47781-652

teriparatide

Teriparatide

teriparatide is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Alvogen, Inc.. The primary component is Teriparatide.

Product ID47781-652_01951749-ee24-0c4d-1e05-c7f7ef965536
NDC47781-652
Product TypeHuman Prescription Drug
Proprietary Nameteriparatide
Generic NameTeriparatide
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2019-11-14
Marketing CategoryNDA / NDA
Application NumberNDA211939
Labeler NameAlvogen, Inc.
Substance NameTERIPARATIDE
Active Ingredient Strength250 ug/mL
Pharm ClassesParathyroid Hormone [CS],Parathyroid Hormone Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 47781-652-89

1 SYRINGE in 1 CARTON (47781-652-89) > 2.48 mL in 1 SYRINGE
Marketing Start Date2019-11-14
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
TERIPARATIDE250 ug/mL

Pharmacological Class

  • Parathyroid Hormone [CS]
  • Parathyroid Hormone Analog [EPC]

NDC Crossover Matching brand name "teriparatide" or generic name "Teriparatide"

NDCBrand NameGeneric Name
0002-8400ForteoTeriparatide
47781-652teriparatideteriparatide

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.